HUMIRA BIOSIMILAR MARKET ANALYSIS

Humira Biosimilar Market, By Product Type (Biosimilar Humira (Adalimumab), and Interchangeable Biosimilar Humira), By Indication (Rheumatoid Arthritis, Psoriasis, Crohn\\\'s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, and Other Autoimmune Conditions), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Patient Age (Adult Patients, Pediatric Patients, and Geriatric Patients), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

• Published In : Nov 2023
• Code : CMI5925
• Pages :155
• Formats :
    Excel and PDF
• Industry : Biotechnology